Clinical Observation of Bevacizumab Combined with S-1 in the Treatment of Pretreated Advanced Esophageal Carcinoma
Conclusion Bevacizumab combined with S-1 was effective and safe for esophageal cancer patients who had recurrent or metastatic diseases after chemoradiation.
Source: Chinese Medical Sciences Journal - Category: Journals (General) Source Type: research
More News: Adenocarcinoma | Avastin | Bleeding | Cancer | Cancer & Oncology | Carcinoma | Epistaxis (Nosebleeds) | Esophagus Cancer | General Medicine | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology